| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.9B | — | — | — | — |
| Op. Income | $386M | — | — | — | — |
| Gross Margin | 93.6% | — | — | — | — |
| Net Margin | 14.8% | — | — | — | — |
| EPS (Diluted) | $15.82 | — | — | — | — |
| Free Cash Flow | $698M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $1.9B |
| Cost of Revenue | $122M |
| GROSS PROFIT | $1.8B |
| R&D Expenses | $0 |
| Selling & Marketing | $47M |
| General & Administrative | $1.2B |
| SG&A Expenses | $1.3B |
| Other Expenses | $123M |
| Operating Expenses | $1.4B |
| Cost & Expenses | $1.5B |
| OPERATING INCOME | $386M |
| Interest Income | $70M |
| Interest Expense | $5M |
| Other Income/Expenses | -$11M |
| INCOME BEFORE TAX | $375M |
| Income Tax Expense | $81M |
| Net Income from Continuing Ops | $294M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $281M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $281M |
| D&A | $27M |
| EBIT | $386M |
| EBITDA | $413M |
| EPS | $17 |
| EPS Diluted | $16 |
| Item | Amount |
|---|---|
| REVENUE | $1.9B |
| Cost of Revenue | $122M |
| GROSS PROFIT | $1.8B |
| R&D Expenses | $0 |
| Selling & Marketing | $47M |
| General & Administrative | $1.2B |
| SG&A Expenses | $1.3B |
| Other Expenses | $123M |
| Operating Expenses | $1.4B |
| Cost & Expenses | $1.5B |
| OPERATING INCOME | $386M |
| Interest Income | $70M |
| Interest Expense | $5M |
| Other Income/Expenses | -$11M |
| INCOME BEFORE TAX | $375M |
| Income Tax Expense | $81M |
| Net Income from Continuing Ops | $294M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $281M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $281M |
| D&A | $27M |
| EBIT | $386M |
| EBITDA | $413M |
| EPS | $17 |
| EPS Diluted | $16 |
| Item | Amount |
|---|---|
| Net Income | $281M |
| Depreciation & Amortization | $27M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $167M |
| Change in Working Capital | $256M |
| OPERATING CASH FLOW | $732M |
| Capital Expenditure | -$35M |
| Acquisitions (Net) | -$9M |
| Purchases of Investments | -$146M |
| Sales/Maturities of Investments | $11M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$178M |
| Net Debt Issuance | $5M |
| Common Stock Repurchased | -$125M |
| Common Dividends Paid | -$114M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$230M |
| FREE CASH FLOW | $698M |
| Net Change in Cash | $327M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $0 |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $0 |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $0 |
| TOTAL NON-CURRENT ASSETS | $0 |
| TOTAL ASSETS | $0 |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | -$1.5B |
| TOTAL NON-CURRENT LIABILITIES | -$1.5B |
| TOTAL LIABILITIES | -$1.5B |
| Common Stock | $0 |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $1.3B |
| Other Equity | $180M |
| TOTAL STOCKHOLDERS' EQUITY | $1.5B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.5B |
| TOTAL LIABILITIES & EQUITY | $0 |
| Total Debt | $0 |
| Net Debt | $0 |
